Inventor · disambiguated record
Jerod Ptacin
Also filed as: PTACIN JEROD · PTACIN JEROD L
23 granted patents·23 pending applications·229 citations·filing 2001–2025
95Inventor score
Top patents by PatentIndex Score
46 records- 0196US11077195B2IL-2 conjugates and methods of use thereofSYNTHORX INC·Filed 2020·Granted Aug 3, 2021·11 cites·33 claims
- 0296US10610571B2Cytokine conjugates for the treatment of proliferative and infectious diseasesSYNTHORX INC·Filed 2019·Granted Apr 7, 2020·30 cites·30 claims
- 0395US11701407B2Cytokine conjugates for the treatment of proliferative and infectious diseasesSYNTHORX INC·Filed 2020·Granted Jul 18, 2023·7 cites·28 claims
- 0495US11622993B2Cytokine conjugates for the treatment of autoimmune diseasesSYNTHORX INC·Filed 2018·Granted Apr 11, 2023·9 cites·19 claims
- 0594US7541147B2Materials and methods for detection of nucleic acidsERAGEN BIOSCIENCES INC·Filed 2006·Granted Jun 2, 2009·21 cites·12 claims
- 0693US12377131B2Cytokine conjugates for the treatment of autoimmune diseasesSYNTHORX INC·Filed 2023·Granted Aug 5, 2025·1 cites·23 claims
- 0793US7422850B2Materials and methods for detection of nucleic acidsERAGEN BIOSCIENCES INC·Filed 2001·Granted Sep 9, 2008·49 cites·16 claims
- 0893US6977161B2Solid support assay systems and methods utilizing non-standard basesERAGEN BIOSCIENCES INC·Filed 2001·Granted Dec 20, 2005·66 cites·11 claims
- 0992US11834689B2Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2021·Granted Dec 5, 2023·4 cites·25 claims
- 1092US7517651B2Materials and methods for detection of nucleic acidsERAGEN BIOSCIENCES INC·Filed 2006·Granted Apr 14, 2009·15 cites·8 claims
- 1189US7892796B2Solid support assay systems and methods utilizing non-standard basesERAGEN BIOSCIENCES INC·Filed 2005·Granted Feb 22, 2011·6 cites·13 claims
- 1287US8217160B2Solid support assay systems and methods utilizing non-standard basesGRENIER JENNIFER K·Filed 2006·Granted Jul 10, 2012·6 cites·15 claims
- 1386US8518671B2Solid support assay systems and methods utilizing non-standard basesGRENIER JENNIFER K·Filed 2012·Granted Aug 27, 2013·4 cites·12 claims
- 1485US12318431B2Cytokine conjugates for the treatment of proliferative and infectious diseasesSYNTHORX INC·Filed 2023·Granted Jun 3, 2025·0 cites·21 claims
- 1585US2025325633A1Cytokine conjugates for the treatment of autoimmune diseasesSYNTHORX INC·Filed 2025·Application pending·0 cites
- 1683US12319944B2Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2023·Granted Jun 3, 2025·0 cites·28 claims
- 1783US2025084410A1Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2024·Application pending·0 cites
- 1878US2025270535A1Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2025·Application pending·0 cites
- 1975US2025154218A1IL-2 Conjugates and Methods of Use to Treat Autoimmune DiseasesSYNTHORX INC·Filed 2024·Application pending·0 cites
- 2074US2024383957A1IL-15 Conjugates and Uses ThereofSYNTHORX INC·Filed 2024·Application pending·0 cites
- 2174US2025325632A1Cytokine conjugates for the treatment of proliferative and infectious diseasesSYNTHORX INC·Filed 2025·Application pending·0 cites
- 2273US2024287151A1IL-15 Conjugates and Uses ThereofSYNTHORX INC·Filed 2024·Application pending·0 cites
- 2371US9611509B2Materials and methods for detection of nucleic acidsLUMINEX CORP·Filed 2013·Granted Apr 4, 2017·0 cites·7 claims
- 2471US8969047B2Solid support assay systems and methods utilizing non-standard basesLUMINEX CORP·Filed 2013·Granted Mar 3, 2015·0 cites·9 claims
- 2570US2009226926A1Materials and methods for detection of nucleic acidsMARSHALL DAVID J·Filed 2009·Application pending·0 cites
- 2669US2024245792A1Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumabSYNTHORX INC·Filed 2023·Application pending·0 cites
- 2769US2019376054A1Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2019·Application pending·0 cites
- 2869US2024226309A1Head and neck cancer combination therapy comprising an il-2 conjugate and cetuximabSYNTHORX INC·Filed 2023·Application pending·0 cites
- 2968US2020024597A1Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2019·Application pending·0 cites
- 3067US2025353926A1Crosslinking multispecific antibodiesENLAZA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3166US11919934B2IL-15 conjugates and uses thereofSYNTHORX INC·Filed 2020·Granted Mar 5, 2024·0 cites·21 claims
- 3265US2020131555A1Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2018·Application pending·0 cites
- 3364US2023416327A1Immuno oncology therapies with il-2 conjugatesSYNTHORX INC·Filed 2023·Application pending·0 cites
- 3463US10240189B2Solid support assay systems and methods utilizing non-standard basesLUMINEX CORP·Filed 2015·Granted Mar 26, 2019·0 cites·10 claims
- 3563US2023277627A1Immuno oncology combination therapy with il-2 conjugates and pembrolizumabSYNTHORX INC·Filed 2023·Application pending·0 cites
- 3662US12344648B2IL-15 conjugates and uses thereofSYNTHORX INC·Filed 2020·Granted Jul 1, 2025·0 cites·33 claims
- 3762US12234271B2Il-2 conjugates and methods of use to treat autoimmune diseasesSYNTHORX INC·Filed 2020·Granted Feb 25, 2025·0 cites·57 claims
- 3862US2020246467A1Il-2 conjugates and methods of use thereofSYNTHORX INC·Filed 2020·Application pending·0 cites
- 3959US2022273767A1Interleukin 10 Conjugates and Uses ThereofSYNTHORX INC·Filed 2022·Application pending·0 cites
- 4059US2023381335A1Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereofSYNTHORX INC·Filed 2023·Application pending·0 cites
- 4158US8519117B2Materials and methods for detection of nucleic acidsMARSHALL DAVID J·Filed 2010·Granted Aug 27, 2013·0 cites·3 claims
- 4258US2025302950A1Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumabSYNTHORX INC·Filed 2022·Application pending·0 cites
- 4357US12491254B2Interleukin 10 conjugates and uses thereofSYNTHORX INC·Filed 2021·Granted Dec 9, 2025·0 cites·18 claims
- 4455US2017369871A1Incorporation of unnatural nucleotides and methods thereofSYNTHORX INC·Filed 2016·Application pending·0 cites
- 4550US2021046160A1Immuno Oncology Combination Therapies With IL-2 ConjugatesSYNTHORX INC·Filed 2020·Application pending·0 cites
- 4648US2022016252A1Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodiesSYNTHORX INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jerod Ptacin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →